Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Hemostemix Inc (HMTXF)

Hemostemix Inc (HMTXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0610 +60.33%
on 04/22/25
0.0978 unch
on 05/20/25
+0.0284 (+40.92%)
since 04/17/25
3-Month
0.0540 +81.11%
on 03/31/25
0.1410 -30.64%
on 02/26/25
-0.0418 (-29.94%)
since 02/20/25
52-Week
0.0240 +307.50%
on 07/22/24
0.2850 -65.68%
on 01/24/25
+0.0678 (+226.00%)
since 05/15/24

Most Recent Stories

More News
Hemostemix Presents at TERMIS 2025, Freiburg, Germany

Freiburg, Germany--(Newsfile Corp. - May 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF), a leading Phase III clinical-stage biotechnology company developing autologous stem cell therapies for cardiovascular...

HMTXF : 0.0978 (+38.33%)
HEM.VN : 0.130 (+30.00%)
Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share

Calgary, Alberta--(Newsfile Corp. - May 12, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), per the Company's February 4, 2025 news release, closed the previously...

HMTXF : 0.0978 (+38.33%)
HEM.VN : 0.130 (+30.00%)
Hemostemix at Invest Stuttgart

Calgary, Alberta--(Newsfile Corp. - May 8, 2025) -  Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is poised to make a significant impact at Invest Stuttgart 2025,...

HMTXF : 0.0978 (+38.33%)
HEM.VN : 0.130 (+30.00%)
Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio

Calgary, Alberta--(Newsfile Corp. - April 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) a leader in the development of autologous stem cell therapy for the treatment of cardiovascular...

HMTXF : 0.0978 (+38.33%)
HEM.VN : 0.130 (+30.00%)
Hemostemix's Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial

Calgary, Alberta--(Newsfile Corp. - March 17, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated...

HMTXF : 0.0978 (+38.33%)
HEM.VN : 0.130 (+30.00%)
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementiaCalgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix...

AIFF : 3.38 (-1.17%)
HMTXF : 0.0978 (+38.33%)
HEM.VN : 0.130 (+30.00%)
Hemostemix Sells Its 23rd ACP-01 Therapy Convertible Debenture

Calgary, Alberta--(Newsfile Corp. - March 5, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell therapy company that has safely...

HMTXF : 0.0978 (+38.33%)
HEM.VN : 0.130 (+30.00%)
RETRANSMISSION: Hemostemix Licenses CytoImmune's BioReactor Technologies

Calgary, Alberta--(Newsfile Corp. - February 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is delighted to announce a strategic breakthrough that secures...

HMTXF : 0.0978 (+38.33%)
HEM.VN : 0.130 (+30.00%)
Hemostemix Licenses CytoImmune's BioReactor Technologies

Calgary, Alberta--(Newsfile Corp. - February 19, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is delighted to announce a strategic breakthrough that secures...

HMTXF : 0.0978 (+38.33%)
HEM.VN : 0.130 (+30.00%)
Hemostemix Provides Corporate Update

Calgary, Alberta--(Newsfile Corp. - February 13, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") announces that, at the request of the Canadian Investment...

HMTXF : 0.0978 (+38.33%)
HEM.VN : 0.130 (+30.00%)

Key Turning Points

3rd Resistance Point 0.1349
2nd Resistance Point 0.1163
1st Resistance Point 0.1071
Last Price 0.0978
1st Support Level 0.0793
2nd Support Level 0.0607
3rd Support Level 0.0515

See More

52-Week High 0.2850
Fibonacci 61.8% 0.1853
Fibonacci 50% 0.1545
Fibonacci 38.2% 0.1237
Last Price 0.0978
52-Week Low 0.0240

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar